Entry Point Capital, LLC Ani Pharmaceuticals Inc Call Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIP
# of Institutions
202Shares Held
15.5MCall Options Held
24KPut Options Held
7.7K-
Black Rock Inc. New York, NY2.66MShares$155 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$84.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX655KShares$38.3 Million0.01% of portfolio
-
State Street Corp Boston, MA645KShares$37.7 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY604KShares$35.2 Million1.14% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.02B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...